Cargando…

Potential clinical application of RNAi‐based therapeutic strategies for treatment of chronic hepatitis B

Detalles Bibliográficos
Autor principal:	Zhaori, Getu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331337/ https://www.ncbi.nlm.nih.gov/pubmed/32851222 http://dx.doi.org/10.1002/ped4.12018

Ejemplares similares

RNAi technique, how far is it from pediatrics?
por: Zhaori, Getu
Publicado: (2017)

Smoke evacuation, is it important for prevention of COVID‐19?
por: Zhaori, Getu
Publicado: (2020)

Better design leads to better results – Importance of virological outcome design in clinical trials for antiviral treatment of coronavirus disease 2019
por: Zhaori, Getu, et al.
Publicado: (2023)

The Business of RNAi Therapeutics in 2012
por: Haussecker, Dirk
Publicado: (2012)

Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
por: Wooddell, Christine I, et al.
Publicado: (2013)

Severe acute hepatitis of unknown causes in children – Current findings, questions, opinions, and recommendations, a mini‐review
por: Zhaori, Getu
Publicado: (2022)

A new column in this journal – Forum on Clinical Investigation
por: Zhaori, Getu
Publicado: (2023)

The Search for Cost-Effective Treatment of Chronic Hepatitis B
por: Smith, Vanessa E., et al.
Publicado: (2008)

Further standardization and safety issues for antiviral therapy during pregnancy
por: Zhaori, Getu
Publicado: (2020)

Old problem may have new solution
por: Zhaori, Getu
Publicado: (2018)

Pediatric Investigation, what differences can it make?
por: Zhaori, Getu
Publicado: (2017)

Chylothorax in infants and children in China, a very good start
por: Zhaori, Getu
Publicado: (2018)

Professor Robert Freedman and his contributions to psychiatric research
por: Zhaori, Getu
Publicado: (2020)

Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants – Importance of design
por: Zhaori, Getu
Publicado: (2023)

MicroRNAs that interfere with RNAi
por: Massirer, Katlin B., et al.
Publicado: (2013)

Progresses in clinical studies on antiviral therapies for COVID‐19—Experience and lessons in design of clinical trials
por: Zhaori, Getu, et al.
Publicado: (2020)

Endogenous RNAi and adaptation to environment in C. elegans
por: Grishok, Alla
Publicado: (2012)

Congenital chylothorax: Rare disease, wide concern
por: Shen, Kunling, et al.
Publicado: (2017)

Collaborative studies of U.S.–China neurologists on acute motor axonal neuropathy
por: Lv, Junlan, et al.
Publicado: (2022)

Novel therapeutic strategies for chronic hepatitis B
por: Phillips, Sandra, et al.
Publicado: (2022)

Functional cure of chronic hepatitis B – predictable?
por: Gerlich, Wolfram
Publicado: (2021)

Traditional Chinese herbal medicine-potential therapeutic application for the treatment of COVID-19
por: Capodice, Jillian L., et al.
Publicado: (2021)

Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
por: Ruiz de Porras, Vicenç
Publicado: (2022)

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
por: van den Berg, Fiona, et al.
Publicado: (2020)

Clinical applications of therapeutic phlebotomy
por: Kim, Kyung Hee, et al.
Publicado: (2016)

RNAi for Treating Hepatitis B Viral Infection
por: Chen, Yong, et al.
Publicado: (2007)

RNAi therapeutic strategies for acute respiratory distress syndrome
por: Jagrosse, Melissa L., et al.
Publicado: (2019)

Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
por: Kadelka, Sarah, et al.
Publicado: (2021)

An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B
por: Machin, Nicoletta, et al.
Publicado: (2018)

Right on target: The next class of efficient, safe, and specific RNAi triggers
por: Becker, Jonas, et al.
Publicado: (2022)

RNAi, a new therapeutic strategy against viral infection
por: TAN, Fischer L, et al.
Publicado: (2004)

Applied RNAi: from fundamental research to therapeutic applications
por: Mari, Bernard, et al.
Publicado: (2014)

Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbation
por: Chen, C-C, et al.
Publicado: (2012)

Management of chronic hepatitis B patients: Efficacy & limitation of nucleos(t)ide analogues
por: Inoue, Jun, et al.
Publicado: (2011)

Therapeutic vaccination for treatment of chronic hepatitis B
por: Cargill, Tamsin, et al.
Publicado: (2021)

Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer
por: Jung, Hun Soon, et al.
Publicado: (2015)

Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases
por: Abdelaal, Ahmed M, et al.
Publicado: (2021)

Antitumor therapeutic application of self-assembled RNAi-AuNP nanoconstructs: Combination of VEGF-RNAi and photothermal ablation
por: Son, Sejin, et al.
Publicado: (2017)

Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients
por: Sha, Rula, et al.
Publicado: (2023)

RNAi therapeutics: a potential new class of pharmaceutical drugs
por: Bumcrot, David, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_fig1dkhjr16e22p8ppmpfqikgq